Common use of Granting funds Clause in Contracts

Granting funds. 1.1 On the basis of the grant application “Demonstration of the applicability of Hookipa’s arenaviral vector technologies for cancer immunotherapy development,” which was received via eCall on 05/31/2016, and on the basis of the expert decision of the advisory board in the 09/13/2016 meeting, funding will be granted for the following project: Project number: 857224 eCall number: 8000616 Pre-project no: 849137 Project name (subject-matter of Contract): Demonstration of the applicability of Hookipa’s arenaviral vector technologies for cancer immunotherapy development Program: General Program Österreichische Tel.: +43 (0) 5 7755 — 0 UniCredit Bank Austria AG Forschungsförderungsgesellschaft mbH Fax +43 (0)5 7755 — 97900 Account no. 1021672700, Routing no. 12000 Xxxxxxxxxxx 0 xxx.xxx.xx, xxxxxx@xxx.xx IBAN AT 66 0000 0000 0000 7200 1090 Vienna FN 000000x Xxxxxxxxxx Xxxxx Xxxxxx SWIFT XXXXXXXX

Appears in 2 contracts

Samples: HOOKIPA Pharma Inc., HOOKIPA Pharma Inc.

AutoNDA by SimpleDocs

Granting funds. 1.1 On the basis of the grant application “Demonstration Development of the applicability of innovative cancer immunotherapies based on Hookipa’s arenaviral vector technologies for cancer immunotherapy developmentVaxwave® technology,” which was received via eCall on 05/31/201610/01/2014, and on the basis of the expert decision of the advisory board in the 09/13/2016 12/03/2014 meeting, funding will be granted for the following project: Project number: 857224 849137 eCall number: 8000616 Pre-project no: 849137 5040485 Project name (subject-matter of Contract): Demonstration Development of the applicability of innovative cancer immunotherapies based on Hookipa’s arenaviral vector technologies for cancer immunotherapy development Vaxwave® technology Program: General Program Österreichische Tel.: Tel +43 (0) 5 0)5 7755 — 0 UniCredit Bank Austria AG Forschungsförderungsgesellschaft mbH Fax +43 (0)5 7755 — 97900 Account no. 102167270010216727200, Routing no. 12000 Xxxxxxxxxxx 0 xxx.xxx.xx, xxxxxx@xxx.xx IBAN AT 66 XX00 0000 0000 0000 7200 0000 1090 Vienna FN 000000x Xxxxxxxxxx Xxxxx Xxxxxx 252263.a Commercial Court Vienna SWIFT XXXXXXXXBKAUATVVW

Appears in 2 contracts

Samples: HOOKIPA Pharma Inc., HOOKIPA Pharma Inc.

AutoNDA by SimpleDocs

Granting funds. 1.1 On the basis of the grant application “Demonstration Development of the applicability of innovative cancer immunotherapies based on Hookipa’s arenaviral vector technologies for cancer immunotherapy developmentVaxwave® technology,” which was received via eCall on 05/31/201610/01/2014, and on the basis of the expert decision of the advisory board in the 09/13/2016 12/03/2014 meeting, funding will be granted for the following project: Project number: 857224 849137 eCall number: 8000616 Pre-project no: 849137 5040485 Project name (subject-matter of Contract): Demonstration Development of the applicability of innovative cancer immunotherapies based on Hookipa’s arenaviral vector technologies for cancer immunotherapy development Vaxwave® technology Program: General Program Österreichische Tel.: Tel +43 (0) 5 0)5 7755 — 0 UniCredit Bank Austria AG Forschungsförderungsgesellschaft mbH Fax +43 (0)5 7755 — 97900 Account no. 102167270010216727200, Routing no. 12000 Xxxxxxxxxxx 0 xxx.xxx.xx, xxxxxx@xxx.xx IBAN AT 66 XX00 0000 0000 0000 7200 0000 1090 Vienna FN 000000x Xxxxxxxxxx Xxxxx Xxxxxx SWIFT XXXXXXXX

Appears in 2 contracts

Samples: HOOKIPA Pharma Inc., HOOKIPA Pharma Inc.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!